IPD cases in adults ≥18 years; PCV13 serotypes accounted for 53% in 2009 and 25% of IPD in 2016. The correlations between IPD (ABC) with INV pneumonia (SENTRY) and N-INV pneumonia (SENTRY) were: 0.937 and 0.973 (both P < 0.01), respectively ( Table 1 ). The proportion of IPD and N-INV pneumonia due to vaccine serotypes decreased consistently and monotonically until 2014 and then plateaued (Figure 1) .
Background. S. pneumoniae (SP) is one of the most important bacteria for pneumonia among adults. We investigated hospital-based proportion of antimicrobial resistance, distribution of serotypes, sequence types (STs) and clinical findings among adult pneumococcal pneumonia patients, and compared microbiological results with the previous study that was reported 10 years ago in Japan.
Methods. A multicenter prospective surveillance for adult pneumonia was conducted from September 2011 to August 2014 in Japan. We enrolled aged over 15 years, community-acquired or healthcare-associated pneumonia patients, and obtained clinical information and sputum samples. Sputum samples were cultured quantitatively or qualitatively at each study sites. Identified SP strains were transported to our laboratory for serotyping by the Quellung reaction. We also extracted DNA from SP strains for multilocus sequence typing. Antimicrobial sensitivity tests for penicillin (PCG), ceftriaxone (CTRX), and meropenem (MEPM) were conducted using agar dilution method. Differences of clinical findings were analyzed using the chi-square test.
Results. We enrolled 200 cases and obtained 205 SP strains. Most dominant serotype was three (24.4%) and ST was 180 (22.9%). Those results were same as the previous report. The proportion of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine serotypes was 58.5 and 75.6%, respectively. Most of SP strains were sensitive for antibiotics (96.1% for PCG, 94.1% for CTRX, and 81.5% for MEPM) and the antimicrobial sensitivity also did not greatly have a change with the previous study reported 10 years ago. Pneumococcal pneumonia patients due to serotype 3 was higher hospitalization rate and CURB-65 score than other serotypes (hospitalization rate was 73.5 and 60.3%, respectively; P = 0.095, and proportion of 3 or more CURB-65 score was 36.4 and 20.7%, respectively; P = 0.039).
Conclusion. In Japan, SP sensitivity for antibiotics, dominant serotype and ST were not changed so much from 10 years ago. Serotype 3 SP contributed to the disease severity of adult pneumococcal pneumonia in Japan.
Disclosures. K. Morimoto, Pfizer: speaker, Speaker honorarium. Background. According to the National Alliance on Mental Illness, one in five American adults experiences a mental health condition every year. CAP is often treated with antibiotics that can prolong the QTc interval. The primary outcome was to assess whether those with a psychiatric disorder were more likely to experience treatment failure and have poor outcomes in the treatment of community acquired pneumonia (CAP).
Impact of Mental
Methods. A retrospective chart review was performed using ICD-9/10 codes for CAP between January 1, 2008 and January 31, 2018. Patients were included if they were seen at the Western New York VA Healthcare System, emergency room, primary or rural care clinics. Data were analyzed via the Student's t-test or chi-squared test.
Results. A total of 518 patients met criteria and 49% had a psychiatric disorder. Compared with patients without psychiatric disorders, patients with psychiatric co-morbidity were more likely to receive an appropriate dose of antibiotics (99.4% vs. 93.6% P = 0.0004) as well as an appropriate duration (78% vs. 68% P = 0.03). Patients with a psychiatric disorder were not more likely to experience failure or subsequent admission. There was no statically significant difference in early or late CAP treatment failure in those with a psychiatric disorder compared with those without (P = 0.3383; P = 0.116). There was also no statistically significant difference in 30-day readmission rates, 30-day mortality, or 90-day mortality (P = 0.4095; P = 0.3383; P = 0.3790). They were more likely to be prescribed conditional risk QTc prolonging agents concomitantly (70.2% vs. 26.9% P < 0.0001); however, differences in prescribing rates of a QTc prolonging antibiotic, such as a fluoroquinolone or macrolide, were not statistically significant (85.3% vs. 83.4% P = 0.5353).
Conclusion. While mental illness is often associated with poor outcomes, this study emphasizes the need to continue to remove the stigma of mental illness when treating patients with common outpatient infections.
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